nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Abdominal pain—Dactinomycin—kidney cancer	0.000443	0.000443	CcSEcCtD
Fondaparinux sodium—Asthenia—Sorafenib—kidney cancer	0.000441	0.000441	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Doxorubicin—kidney cancer	0.000439	0.000439	CcSEcCtD
Fondaparinux sodium—Vertigo—Paclitaxel—kidney cancer	0.000438	0.000438	CcSEcCtD
Fondaparinux sodium—Syncope—Paclitaxel—kidney cancer	0.000437	0.000437	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000437	0.000437	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Sunitinib—kidney cancer	0.000436	0.000436	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Vincristine—kidney cancer	0.000435	0.000435	CcSEcCtD
Fondaparinux sodium—Pruritus—Sorafenib—kidney cancer	0.000435	0.000435	CcSEcCtD
Fondaparinux sodium—Vomiting—Erlotinib—kidney cancer	0.000435	0.000435	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Vincristine—kidney cancer	0.000432	0.000432	CcSEcCtD
Fondaparinux sodium—Fatigue—Vincristine—kidney cancer	0.000432	0.000432	CcSEcCtD
Fondaparinux sodium—Rash—Erlotinib—kidney cancer	0.000431	0.000431	CcSEcCtD
Fondaparinux sodium—Dermatitis—Erlotinib—kidney cancer	0.000431	0.000431	CcSEcCtD
Fondaparinux sodium—Palpitations—Paclitaxel—kidney cancer	0.000431	0.000431	CcSEcCtD
Fondaparinux sodium—Insomnia—Gemcitabine—kidney cancer	0.00043	0.00043	CcSEcCtD
Fondaparinux sodium—Headache—Erlotinib—kidney cancer	0.000428	0.000428	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Paclitaxel—kidney cancer	0.000428	0.000428	CcSEcCtD
Fondaparinux sodium—Pain—Vincristine—kidney cancer	0.000428	0.000428	CcSEcCtD
Fondaparinux sodium—Constipation—Vincristine—kidney cancer	0.000428	0.000428	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—kidney cancer	0.000428	0.000428	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Gemcitabine—kidney cancer	0.000427	0.000427	CcSEcCtD
Fondaparinux sodium—Flushing—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Fondaparinux sodium—Cough—Paclitaxel—kidney cancer	0.000425	0.000425	CcSEcCtD
Fondaparinux sodium—Asthenia—Sunitinib—kidney cancer	0.000425	0.000425	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Gemcitabine—kidney cancer	0.000424	0.000424	CcSEcCtD
Fondaparinux sodium—Nausea—Vinblastine—kidney cancer	0.000423	0.000423	CcSEcCtD
Fondaparinux sodium—Somnolence—Gemcitabine—kidney cancer	0.000422	0.000422	CcSEcCtD
Fondaparinux sodium—Convulsion—Paclitaxel—kidney cancer	0.000422	0.000422	CcSEcCtD
Fondaparinux sodium—Nausea—Everolimus—kidney cancer	0.000421	0.000421	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Sorafenib—kidney cancer	0.000421	0.000421	CcSEcCtD
Fondaparinux sodium—Pruritus—Sunitinib—kidney cancer	0.000419	0.000419	CcSEcCtD
Fondaparinux sodium—Angiopathy—Capecitabine—kidney cancer	0.000417	0.000417	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Capecitabine—kidney cancer	0.000415	0.000415	CcSEcCtD
Fondaparinux sodium—Chest pain—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Capecitabine—kidney cancer	0.000414	0.000414	CcSEcCtD
Fondaparinux sodium—Anxiety—Paclitaxel—kidney cancer	0.000413	0.000413	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Gemcitabine—kidney cancer	0.000413	0.000413	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Dactinomycin—kidney cancer	0.000413	0.000413	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000412	0.000412	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Capecitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Fondaparinux sodium—Fatigue—Gemcitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Vincristine—kidney cancer	0.000409	0.000409	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—kidney cancer	0.000407	0.000407	CcSEcCtD
Fondaparinux sodium—Dizziness—Sorafenib—kidney cancer	0.000407	0.000407	CcSEcCtD
Fondaparinux sodium—Pain—Gemcitabine—kidney cancer	0.000406	0.000406	CcSEcCtD
Fondaparinux sodium—Constipation—Gemcitabine—kidney cancer	0.000406	0.000406	CcSEcCtD
Fondaparinux sodium—Nausea—Erlotinib—kidney cancer	0.000406	0.000406	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Sunitinib—kidney cancer	0.000405	0.000405	CcSEcCtD
Fondaparinux sodium—Asthenia—Dactinomycin—kidney cancer	0.000402	0.000402	CcSEcCtD
Fondaparinux sodium—Confusional state—Paclitaxel—kidney cancer	0.000401	0.000401	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—kidney cancer	0.000401	0.000401	CcSEcCtD
Fondaparinux sodium—Malnutrition—Capecitabine—kidney cancer	0.0004	0.0004	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—kidney cancer	0.000398	0.000398	CcSEcCtD
Fondaparinux sodium—Oedema—Paclitaxel—kidney cancer	0.000398	0.000398	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Paclitaxel—kidney cancer	0.000398	0.000398	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Vincristine—kidney cancer	0.000396	0.000396	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Vincristine—kidney cancer	0.000396	0.000396	CcSEcCtD
Fondaparinux sodium—Infection—Paclitaxel—kidney cancer	0.000395	0.000395	CcSEcCtD
Fondaparinux sodium—Flatulence—Capecitabine—kidney cancer	0.000394	0.000394	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Capecitabine—kidney cancer	0.000392	0.000392	CcSEcCtD
Fondaparinux sodium—Dizziness—Sunitinib—kidney cancer	0.000392	0.000392	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Gemcitabine—kidney cancer	0.000391	0.000391	CcSEcCtD
Fondaparinux sodium—Shock—Paclitaxel—kidney cancer	0.000391	0.000391	CcSEcCtD
Fondaparinux sodium—Vomiting—Sorafenib—kidney cancer	0.000391	0.000391	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Paclitaxel—kidney cancer	0.00039	0.00039	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—kidney cancer	0.00039	0.00039	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Paclitaxel—kidney cancer	0.000389	0.000389	CcSEcCtD
Fondaparinux sodium—Tachycardia—Paclitaxel—kidney cancer	0.000388	0.000388	CcSEcCtD
Fondaparinux sodium—Rash—Sorafenib—kidney cancer	0.000388	0.000388	CcSEcCtD
Fondaparinux sodium—Dermatitis—Sorafenib—kidney cancer	0.000388	0.000388	CcSEcCtD
Fondaparinux sodium—Back pain—Capecitabine—kidney cancer	0.000387	0.000387	CcSEcCtD
Fondaparinux sodium—Skin disorder—Paclitaxel—kidney cancer	0.000386	0.000386	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000385	0.000385	CcSEcCtD
Fondaparinux sodium—Headache—Sorafenib—kidney cancer	0.000385	0.000385	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Paclitaxel—kidney cancer	0.000385	0.000385	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—kidney cancer	0.000384	0.000384	CcSEcCtD
Fondaparinux sodium—Anorexia—Paclitaxel—kidney cancer	0.000379	0.000379	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—kidney cancer	0.000379	0.000379	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000378	0.000378	CcSEcCtD
Fondaparinux sodium—Vision blurred—Capecitabine—kidney cancer	0.000377	0.000377	CcSEcCtD
Fondaparinux sodium—Vomiting—Sunitinib—kidney cancer	0.000376	0.000376	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Gemcitabine—kidney cancer	0.000376	0.000376	CcSEcCtD
Fondaparinux sodium—Rash—Sunitinib—kidney cancer	0.000373	0.000373	CcSEcCtD
Fondaparinux sodium—Dermatitis—Sunitinib—kidney cancer	0.000373	0.000373	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—kidney cancer	0.000372	0.000372	CcSEcCtD
Fondaparinux sodium—Hypotension—Paclitaxel—kidney cancer	0.000372	0.000372	CcSEcCtD
Fondaparinux sodium—Headache—Sunitinib—kidney cancer	0.000371	0.000371	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—kidney cancer	0.00037	0.00037	CcSEcCtD
Fondaparinux sodium—Anaemia—Capecitabine—kidney cancer	0.00037	0.00037	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Vincristine—kidney cancer	0.000369	0.000369	CcSEcCtD
Fondaparinux sodium—Nausea—Sorafenib—kidney cancer	0.000365	0.000365	CcSEcCtD
Fondaparinux sodium—Insomnia—Paclitaxel—kidney cancer	0.00036	0.00036	CcSEcCtD
Fondaparinux sodium—Vertigo—Capecitabine—kidney cancer	0.000359	0.000359	CcSEcCtD
Fondaparinux sodium—Asthenia—Vincristine—kidney cancer	0.000359	0.000359	CcSEcCtD
Fondaparinux sodium—Syncope—Capecitabine—kidney cancer	0.000359	0.000359	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Paclitaxel—kidney cancer	0.000357	0.000357	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—kidney cancer	0.000356	0.000356	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—kidney cancer	0.000356	0.000356	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Paclitaxel—kidney cancer	0.000355	0.000355	CcSEcCtD
Fondaparinux sodium—Somnolence—Paclitaxel—kidney cancer	0.000354	0.000354	CcSEcCtD
Fondaparinux sodium—Palpitations—Capecitabine—kidney cancer	0.000353	0.000353	CcSEcCtD
Fondaparinux sodium—Rash—Dactinomycin—kidney cancer	0.000353	0.000353	CcSEcCtD
Fondaparinux sodium—Nausea—Sunitinib—kidney cancer	0.000352	0.000352	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Capecitabine—kidney cancer	0.000352	0.000352	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Paclitaxel—kidney cancer	0.00035	0.00035	CcSEcCtD
Fondaparinux sodium—Cough—Capecitabine—kidney cancer	0.000349	0.000349	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Paclitaxel—kidney cancer	0.000346	0.000346	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000343	0.000343	CcSEcCtD
Fondaparinux sodium—Fatigue—Paclitaxel—kidney cancer	0.000343	0.000343	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vincristine—kidney cancer	0.000343	0.000343	CcSEcCtD
Fondaparinux sodium—Asthenia—Gemcitabine—kidney cancer	0.000341	0.000341	CcSEcCtD
Fondaparinux sodium—Chest pain—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Fondaparinux sodium—Pain—Paclitaxel—kidney cancer	0.00034	0.00034	CcSEcCtD
Fondaparinux sodium—Constipation—Paclitaxel—kidney cancer	0.00034	0.00034	CcSEcCtD
Fondaparinux sodium—Anxiety—Capecitabine—kidney cancer	0.000339	0.000339	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000338	0.000338	CcSEcCtD
Fondaparinux sodium—Pruritus—Gemcitabine—kidney cancer	0.000336	0.000336	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—kidney cancer	0.000333	0.000333	CcSEcCtD
Fondaparinux sodium—Dizziness—Vincristine—kidney cancer	0.000331	0.000331	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—kidney cancer	0.00033	0.00033	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—kidney cancer	0.00033	0.00033	CcSEcCtD
Fondaparinux sodium—Confusional state—Capecitabine—kidney cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Paclitaxel—kidney cancer	0.000328	0.000328	CcSEcCtD
Fondaparinux sodium—Oedema—Capecitabine—kidney cancer	0.000326	0.000326	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000325	0.000325	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Gemcitabine—kidney cancer	0.000325	0.000325	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—kidney cancer	0.000324	0.000324	CcSEcCtD
Fondaparinux sodium—Infection—Capecitabine—kidney cancer	0.000324	0.000324	CcSEcCtD
Fondaparinux sodium—Shock—Capecitabine—kidney cancer	0.000321	0.000321	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—kidney cancer	0.000321	0.000321	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Capecitabine—kidney cancer	0.00032	0.00032	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Capecitabine—kidney cancer	0.00032	0.00032	CcSEcCtD
Fondaparinux sodium—Tachycardia—Capecitabine—kidney cancer	0.000319	0.000319	CcSEcCtD
Fondaparinux sodium—Vomiting—Vincristine—kidney cancer	0.000318	0.000318	CcSEcCtD
Fondaparinux sodium—Skin disorder—Capecitabine—kidney cancer	0.000317	0.000317	CcSEcCtD
Fondaparinux sodium—Urticaria—Paclitaxel—kidney cancer	0.000316	0.000316	CcSEcCtD
Fondaparinux sodium—Rash—Vincristine—kidney cancer	0.000316	0.000316	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Capecitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Fondaparinux sodium—Dermatitis—Vincristine—kidney cancer	0.000315	0.000315	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—kidney cancer	0.000315	0.000315	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Paclitaxel—kidney cancer	0.000314	0.000314	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Paclitaxel—kidney cancer	0.000314	0.000314	CcSEcCtD
Fondaparinux sodium—Headache—Vincristine—kidney cancer	0.000314	0.000314	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000312	0.000312	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—kidney cancer	0.000311	0.000311	CcSEcCtD
Fondaparinux sodium—Anorexia—Capecitabine—kidney cancer	0.000311	0.000311	CcSEcCtD
Fondaparinux sodium—Hypotension—Capecitabine—kidney cancer	0.000305	0.000305	CcSEcCtD
Fondaparinux sodium—Vomiting—Gemcitabine—kidney cancer	0.000302	0.000302	CcSEcCtD
Fondaparinux sodium—Rash—Gemcitabine—kidney cancer	0.0003	0.0003	CcSEcCtD
Fondaparinux sodium—Dermatitis—Gemcitabine—kidney cancer	0.000299	0.000299	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Fondaparinux sodium—Headache—Gemcitabine—kidney cancer	0.000298	0.000298	CcSEcCtD
Fondaparinux sodium—Nausea—Vincristine—kidney cancer	0.000297	0.000297	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—kidney cancer	0.000296	0.000296	CcSEcCtD
Fondaparinux sodium—Insomnia—Capecitabine—kidney cancer	0.000295	0.000295	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—kidney cancer	0.000295	0.000295	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Capecitabine—kidney cancer	0.000293	0.000293	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Paclitaxel—kidney cancer	0.000293	0.000293	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—kidney cancer	0.000292	0.000292	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Capecitabine—kidney cancer	0.000291	0.000291	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Capecitabine—kidney cancer	0.000287	0.000287	CcSEcCtD
Fondaparinux sodium—Asthenia—Paclitaxel—kidney cancer	0.000285	0.000285	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Capecitabine—kidney cancer	0.000284	0.000284	CcSEcCtD
Fondaparinux sodium—Nausea—Gemcitabine—kidney cancer	0.000282	0.000282	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000282	0.000282	CcSEcCtD
Fondaparinux sodium—Fatigue—Capecitabine—kidney cancer	0.000281	0.000281	CcSEcCtD
Fondaparinux sodium—Pruritus—Paclitaxel—kidney cancer	0.000281	0.000281	CcSEcCtD
Fondaparinux sodium—Pain—Capecitabine—kidney cancer	0.000279	0.000279	CcSEcCtD
Fondaparinux sodium—Constipation—Capecitabine—kidney cancer	0.000279	0.000279	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—kidney cancer	0.000275	0.000275	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Paclitaxel—kidney cancer	0.000272	0.000272	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Capecitabine—kidney cancer	0.000269	0.000269	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—kidney cancer	0.000269	0.000269	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—kidney cancer	0.000267	0.000267	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Capecitabine—kidney cancer	0.000267	0.000267	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—kidney cancer	0.000267	0.000267	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—kidney cancer	0.000265	0.000265	CcSEcCtD
Fondaparinux sodium—Dizziness—Paclitaxel—kidney cancer	0.000263	0.000263	CcSEcCtD
Fondaparinux sodium—Urticaria—Capecitabine—kidney cancer	0.000259	0.000259	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Capecitabine—kidney cancer	0.000258	0.000258	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Capecitabine—kidney cancer	0.000258	0.000258	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—kidney cancer	0.000258	0.000258	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—kidney cancer	0.000254	0.000254	CcSEcCtD
Fondaparinux sodium—Vomiting—Paclitaxel—kidney cancer	0.000253	0.000253	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—kidney cancer	0.000252	0.000252	CcSEcCtD
Fondaparinux sodium—Rash—Paclitaxel—kidney cancer	0.000251	0.000251	CcSEcCtD
Fondaparinux sodium—Dermatitis—Paclitaxel—kidney cancer	0.000251	0.000251	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Fondaparinux sodium—Headache—Paclitaxel—kidney cancer	0.000249	0.000249	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—kidney cancer	0.000243	0.000243	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Capecitabine—kidney cancer	0.00024	0.00024	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—kidney cancer	0.000238	0.000238	CcSEcCtD
Fondaparinux sodium—Nausea—Paclitaxel—kidney cancer	0.000236	0.000236	CcSEcCtD
Fondaparinux sodium—Asthenia—Capecitabine—kidney cancer	0.000234	0.000234	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—kidney cancer	0.000231	0.000231	CcSEcCtD
Fondaparinux sodium—Pruritus—Capecitabine—kidney cancer	0.000231	0.000231	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—kidney cancer	0.000228	0.000228	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—kidney cancer	0.000227	0.000227	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—kidney cancer	0.000225	0.000225	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—kidney cancer	0.000223	0.000223	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Capecitabine—kidney cancer	0.000223	0.000223	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000218	0.000218	CcSEcCtD
Fondaparinux sodium—Dizziness—Capecitabine—kidney cancer	0.000216	0.000216	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—kidney cancer	0.000212	0.000212	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—kidney cancer	0.00021	0.00021	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—kidney cancer	0.00021	0.00021	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—kidney cancer	0.000209	0.000209	CcSEcCtD
Fondaparinux sodium—Vomiting—Capecitabine—kidney cancer	0.000208	0.000208	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—kidney cancer	0.000207	0.000207	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—kidney cancer	0.000206	0.000206	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—kidney cancer	0.000206	0.000206	CcSEcCtD
Fondaparinux sodium—Rash—Capecitabine—kidney cancer	0.000206	0.000206	CcSEcCtD
Fondaparinux sodium—Dermatitis—Capecitabine—kidney cancer	0.000206	0.000206	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—kidney cancer	0.000205	0.000205	CcSEcCtD
Fondaparinux sodium—Headache—Capecitabine—kidney cancer	0.000204	0.000204	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—kidney cancer	0.000204	0.000204	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—kidney cancer	0.000201	0.000201	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—kidney cancer	0.000197	0.000197	CcSEcCtD
Fondaparinux sodium—Nausea—Capecitabine—kidney cancer	0.000194	0.000194	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—kidney cancer	0.00019	0.00019	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—kidney cancer	0.000189	0.000189	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—kidney cancer	0.000188	0.000188	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—kidney cancer	0.000187	0.000187	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—kidney cancer	0.000185	0.000185	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—kidney cancer	0.000183	0.000183	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000182	0.000182	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—kidney cancer	0.000181	0.000181	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—kidney cancer	0.00018	0.00018	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—kidney cancer	0.00018	0.00018	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—kidney cancer	0.000173	0.000173	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000172	0.000172	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—kidney cancer	0.000167	0.000167	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—kidney cancer	0.000166	0.000166	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—kidney cancer	0.000166	0.000166	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—kidney cancer	0.000155	0.000155	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—kidney cancer	0.000151	0.000151	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—kidney cancer	0.000149	0.000149	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—kidney cancer	0.000144	0.000144	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—kidney cancer	0.000139	0.000139	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—kidney cancer	0.000134	0.000134	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—kidney cancer	0.000133	0.000133	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—kidney cancer	0.000133	0.000133	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—kidney cancer	0.000132	0.000132	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—kidney cancer	0.000125	0.000125	CcSEcCtD
